Literature DB >> 27366564

Prevention of Withdrawal Movement Associated with the Injection of Rocuronium in Children: Comparison of Paracetamol and Lidocaine.

Reyhan Polat1, Mine Akın2, Gülsen Keskin2, Dilek Ünal1, Aslı Dönmez1.   

Abstract

OBJECTIVE: Pain from rocuronium injection is observed in 50%-80 % of patients. This study aimed to compare the effectiveness of pretreatment with paracetamol and lidocaine in preventing pain-induced withdrawal caused by the intravenous injection of rocuronium during the induction of general anaesthesia in paediatric patients.
METHODS: Ninety children were randomized into two groups using a simple drawing from the box method: a paracetamol group (Group P, n=45) and a lidocaine group (Group L, n=45). After anaesthesia induction, venous occlusion was applied by a paediatric cuff inflated to a pressure of 75 mmHg and by 50 mg paracetamol and 0.5 mg kg(-1) lidocaine was injected in Groups P and L, respectively. Venous occlusion was then released, followed by rocuronium injection (0.6 mg kg(-1)). Withdrawal was evaluated using a 4-point scale (1, no response; 2, movement at the wrist only; 3, movement/withdrawal involving arm only (elbow/shoulder) and 4, generalized response, movement/withdrawal in more than one extremity).
RESULTS: The incidence of withdrawal movement was 42% and 26% in the Groups P and L, respectively (p=0.120). Although no significant differences were noted in the number of patients who had no withdrawal movement and mild withdrawal movement in Groups P and L, compared with Group L, the incidences of moderate withdrawal movement were significantly higher in Group P (p<0.05). No patient in either group revealed generalized movement.
CONCLUSION: Using a venous occlusion technique, pretreatment with 50 mg paracetamol can prevent withdrawal movement caused by rocuronium injection in children but is not as effective as lidocaine to prevent moderate withdrawal movement.

Entities:  

Keywords:  Rocuronium; lidocaine; paracetamol; withdrawal movement

Year:  2016        PMID: 27366564      PMCID: PMC4894203          DOI: 10.5152/TJAR.2016.20981

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


  23 in total

1.  Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation.

Authors:  Yun-Sil Lee; Hyungsuk Kim; Jaime S Brahim; Janet Rowan; Gloria Lee; Raymond A Dionne
Journal:  Pain       Date:  2006-12-18       Impact factor: 6.961

2.  Rocuronium-induced generalized spontaneous movements cause pulmonary aspiration.

Authors:  Jiin-Tarng Lui; Shin-Jen Huang; Ching-Yue Yang; Jee-Ching Hsu; Ping-Wing Lui
Journal:  Chang Gung Med J       Date:  2002-09

3.  Local warming at injection site helps alleviate pain after rocuronium administration.

Authors:  Charu Mahajan; Girija Prasad Rath; Parmod Kumar Bithal; Hemanshu Prabhakar; Rahul Yadav; Surya Kumar Dube
Journal:  J Anesth       Date:  2010-08-25       Impact factor: 2.078

4.  The effect of intravenous paracetamol for the prevention of rocuronium injection pain.

Authors:  Sennur Uzun; Ismail A Erden; Ozgur Canbay; Ulku Aypar
Journal:  Kaohsiung J Med Sci       Date:  2014-09-22       Impact factor: 2.744

5.  The use of lidocaine for preventing the withdrawal associated with the injection of rocuronium in children and adolescents.

Authors:  Y Shevchenko; J C Jocson; V A McRae; S A Stayer; R E Schwartz; M Rehman; D K Choudhry
Journal:  Anesth Analg       Date:  1999-04       Impact factor: 5.108

6.  Spontaneous movements associated with rocuronium injection: the effects of prior administration of fentanyl.

Authors:  A Borgeat; D Kwiatkowski; Y A Ruetsch
Journal:  J Clin Anesth       Date:  1997-12       Impact factor: 9.452

7.  Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects.

Authors:  F V Abbott; K G Hellemans
Journal:  Behav Brain Res       Date:  2000-07       Impact factor: 3.332

8.  Dilution of rocuronium to 0.5 mg/mL with 0.9% NaCl eliminates the pain during intravenous injection in awake patients.

Authors:  Bahattin Tuncali; Ayse Karci; Binnur Erdalkiran Tuncali; Omur Mavioglu; Cimen Gulben Olguner; Selin Ayhan; Zahide Elar
Journal:  Anesth Analg       Date:  2004-09       Impact factor: 5.108

9.  Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man.

Authors:  Burkhard Hinz; Olga Cheremina; Kay Brune
Journal:  FASEB J       Date:  2007-09-20       Impact factor: 5.191

10.  Effects of lidocaine, ketamine, and remifentanil on withdrawal response of rocuronium.

Authors:  Ki Tae Jung; Hye Ji Kim; Hyo Sung Bae; Hyun Young Lee; Sang Hun Kim; Keum Young So; Kyung Jun Lim; Byung Sik Yu; Jong Dal Jung; Tae Hun An; Hong Chan Park
Journal:  Korean J Anesthesiol       Date:  2014-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.